نتائج البحث

المساهمون: Работа выполнена за счет средств бюджетного финансирования на выполнение государственного задания по теме «Изучение иммунопатологии, диагностики и терапии на ранних стадиях системных ревматических заболеваний» (регистрационный номер 1021051402790-6).

المصدر: Rheumatology Science and Practice; Vol 61, No 3 (2023); 339–348 ; Научно-практическая ревматология; Vol 61, No 3 (2023); 339–348 ; 1995-4492 ; 1995-4484

مصطلحات موضوعية: HOMA-IR, systemic lupus erythematosus, phenotypes, obesity, overweight, body mass index, leptin, hyperleptinemia, insulin resistance, системная красная волчанка, фенотипы, ожирение, избыточный вес, индекс массы тела, лептин, гиперлептинемия, инсулинорезистентность

وصف الملف: application/pdf

العلاقة: https://rsp.mediar-press.net/rsp/article/view/3361/2289Test; Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, et al. Lipid paradox in rheumatoid arthritis: The impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011;70(3):482-487. doi:10.1136/ard.2010.135871; Baker JF, Billig E, Michaud K, Ibrahim S, Caplan L, Cannon GW, et al. Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis. Arthritis Rheumatol. 2015;67(7):1711-1717. doi:10.1002/art.39136; Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2004;50(11):3450-3457. doi:10.1002/art.20612; Santos MJ, Vinagre F, Canas da Silva J, Gil V, Fonseca JE. Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: A comparative study of Caucasian female patients. Clin Exp Rheumatol. 2011;29(3):470-476.; Katz P, Gregorich S, Yazdany J, Trupin L, Julian L, Yelin E, et al. Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63(2):261-268. doi:10.1002/acr.20343; Elkan AC, Engvall IL, Cederholm T, Hafström I. Rheumatoid cachexia, central obesity and malnutrition in patients with lowactive rheumatoid arthritis: Feasibility of anthropometry, mini nutritional assessment and body composition techniques. Eur J Nutr. 2009;48(5):315-322. doi:10.1007/s00394-009-0017-y; Сорокина АО, Демин НВ, Добровольская ОВ, Никитинская ОА, Торопцова НВ, Феклистов АЮ. Патологические фенотипы состава тела у больных ревматическими заболеваниями. Научно-практическая ревматология. 2022;60(4):487-494. doi:10.47360/1995-4484-2022-487-494; Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714-724. doi:10.1016/S2213-8587(18)30137-2; Kim NH, Kim KJ, Choi J, Kim SG. Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical co ronavirus disease 2019 outcomes than metabolically healthy individuals without obesity. Metabolism. 2022;128:154894. doi:10.1016/j.metabol.2021.154894; Stefan N. Metabolically healthy and unhealthy normal weight and obesity. Endocrinol Metab (Seoul). 2020;35(3):487-493. doi:10.3803/EnM.2020.301; Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168(15):1617-1624. doi:10.1001/archinte.168.15.1617; Шляхто ЕВ, Недогода СВ, Конради АО, Баранова ЕИ, Фомин ВВ, Верткин АЛ, и др. Концепция новых национальных клинических рекомендаций по ожирению. Российский кардиологический журнал. 2016;(4):7-13. doi:10.15829/1560-4071-2016-4-7-13; Giraud C, Lambertc C, Dutheild F, Pereirac B, Soubriera M, Tournadre A. The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis. Joint Bone Spine. 2021;88(1):105059. doi:10.1016/j.jbspin.2020.07.008; Frithioff-Bøjsøe C, Lund MAV, Lausten-Thomsen U, Hedley PL, Pedersen O, Christiansen M, et al. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity. Pediatr Diabetes. 2020;21(2):194-202. doi:10.1111/pedi.12964; Bungau S, Behl T, Tit DM, Banica F, Bratu OG, Diaconu CC, et al. Interactions between leptin and insulin resistance in patients with prediabetes, with and without NAFLD. Exp Ther Med. 2020;20(6):197. doi:10.3892/etm.2020.9327; Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol Sin. 2018;39(7):1176-1188. doi:10.1038/aps.2018.40; Bell BB, Rahmouni K. Leptin as a mediator of obesity-induced hypertension. Curr Obes Rep. 2016;5(4):397-404. doi:10.1007/s13679-016-0231-x; Farcaş AD, Rusu A, Stoia MA, Vida-Simiti LA. Plasma leptin, but not resistin, TNF-α and adiponectin, is associated with echocardiographic parameters of cardiac remodeling in patients with coronary artery disease. Cytokine. 2018;103:46-49. doi:10.1016/j.cyto.2018.01.002; Csongrádi É, Káplár M, Nagy B Jr, Koch CA, Juhász A, Bajnok L, et al. Adipokines as atherothrombotic risk factors in obese subjects: Associations with haemostatic markers and common carotid wall thickness. Nutr Metab Cardiovasc Dis. 2017;27(6):571-580. doi:10.1016/j.numecd.2017.02.007; Everson-Rose SA, Barinas-Mitchell EJM, El Khoudary SR, Huang HH, Wang Q, Janssen I, et al. Adipokines and subclinical cardiovascular disease in post-menopausal women: Study of women’s health across the nation. J Am Heart Assoc. 2021;10(7):e019173. doi:10.1161/JAHA.120.019173; Varma B, Ogunmoroti O, Ndumele CE, Zhao D, Szklo M, Sweeney T, et al. Higher leptin levels are associated with coronary artery calcium progression: The Multi-Ethnic Study of Atherosclerosis (MESA). Diabet Epidemiol Manag. 2022;6:100047. doi:10.1016/j.deman.2021.100047; Raman P, Khanal S. Leptin in atherosclerosis: Focus on macrophages, endothelial and smooth muscle cells. Int J Mol Sci. 2021;22(11):5446. doi:10.3390/ijms22115446; Bobbert P, Jenke A, Bobbert T, Kühl U, Rauch U, Lassner D, et al. High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy. Eur J Heart Fail. 2012;14(11):1265-1275. doi:10.1093/eurjhf/hfs111; Puurunen VP, Kiviniemi A, Lepojärvi S, Piira OP, Hedberg P, Junttila J, et al. Leptin predicts short-term major adverse cardiac events in patients with coronary artery disease. Ann Med. 2017;49(5):448-454. doi:10.1080/07853890.2017.1301678; Bickel C, Schnabel RB, Zeller T, Lackner KJ, Rupprecht HJ, Blankenberg S, et al. Predictors of leptin concentration and association with cardiovascular risk in patients with coronary artery disease: Results from the AtheroGene study. Biomarkers. 2017;22(3-4):210-218. doi:10.3109/1354750X.2015.1130745; Ait Eldjoudi D, Cordero Barreal A, Gonzalez-Rodríguez M, Ruiz-Fernández C, Farrag Y, Farrag M, et al. Leptin in osteoarthritis and rheumatoid arthritis: Player or bystander? Int J Mol Sci. 2022;23(5):2859. doi:10.3390/ijms23052859; Lee YH, Bae SC. Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: A meta-analysis. Z Rheumatol. 2016;75(10):1021-1027. doi:10.1007/s00393-016-0050-1; Kuo CY, Tsai TY, Huang YC. Insulin resistance and serum levels of adipokines in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Lupus. 2020;29(9):1078-1084. doi:10.1177/0961203320935185; Villa N, Badla O, Goit R, Saddik SE, Dawood SN, Rabih AM, et al. Role of leptin in systemic lupus erythematosus: Is it still a mystery? Cureus. 2022;14(7):e26751. doi:10.7759/cureus.26751; Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9): 2569-2581. doi:10.1002/art.27584; Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-2686. doi:10.1002/art.34473; Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419. doi:10.1007/BF00280883; Quevedo-Abeledo JC, Sánchez-Pérez H, Tejera-Segura B, de Armas-Rillo L, Ojeda S, Erausquin C, et al. Higher prevalence and degree of insulin resistance in patients with rheumatoid arthritis than in patients with systemic lupus erythematosus. J Rheumatol. 2021;48(3):339-347. doi:10.3899/jrheum.200435; Santos MJ, Vinagre F, Silva JJ, Gil V, Fonseca JE. Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: A comparative study of female patients. Acta Reumatol Port. 2010;35(3):325-332.; Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Avalos I, et al. Inflammation-associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008;58(7):2105-2112. doi:10.1002/art.23600; Contreras-Haro B, Hernandez-Gonzalez SO, Gonzalez-Lopez L, Espinel-Bermudez MC, Garcia-Benavides L, Perez-Guerrero E, et al. Fasting triglycerides and glucose index: A useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosus. Diabetol Metab Syndr. 2019;11:95. doi:10.1186/s13098-019-0495-x; Guimarães MFBR, de Andrade MVM, Machado CJ, Vieira ÉLM, Pinto MRDC, et al. Leptin as an obesity marker in rheumatoid arthritis. Rheumatol Int. 2018;38(9):1671-1677. doi:10.1007/s00296-018-4082-5; La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017;98:51-58. doi:10.1016/j.cyto.2016.10.011; Federico LE, Johnson TM, England BR, Wysham KD, George MD, Sauer B, et al. Circulating adipokines and associations with incident cardiovascular disease in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2023;75(4):768-777. doi:10.1002/acr.24885; Baker JF, England BR, George MD, Wysham K, Johnson T, Kunkel G, et al. Elevations in adipocytokines and mortality in rheumatoid arthritis. Rheumatology (Oxford). 2022;61(12):4924-4934. doi:10.1093/rheumatology/keac191; Marouen S, Barnetche T, Combe B, Morel J, Daïen CI. TNF inhibitors increase fat mass in inflammatory rheumatic disease: A systematic review with meta-analysis. Clin Exp Rheumatol. 2017;35(2):337-343.; Toussirot E. The Interrelations between biological and targeted synthetic agents used in inflammatory joint diseases, and obesity or body composition. Metabolites. 2020;10(3):107. doi:10.3390/metabo10030107; https://rsp.mediar-press.net/rsp/article/view/3361Test